Merind Limited Share Price

Merind Limited Delisted Shares - Company Overview

Merind Limited is a public limited company incorporated in India on Nov. 04, 1958 as a private limited company,  its registered office address is "Readymoney Terrace, 2nd floor, Room no. 5, 167, Dr. Annie Besant Road, Worli, Mumbai,". The Company is a subsidiary of Dartmour Holdings Private Limited. Merind Limited (MERIN), is engaged in the manufacturing and sale of bulk drugs and formulations. it was also known as Merck Sharp & Dhome (India), the name was changed to Merind Limited in December. 17, 1984 when Tatas acquired a 50% stake in equity, from Merck & Company Inc. USA. Wockhardt made an open offer in July 1998 for the acquisition of the entire equity stake in Merind Limited. 

In March 1993, Merind ltd issued 18,00,000 No. of equity shares of Rs.10 each at a premium of Rs.60 per share on a rights basis in the prop. 1:1. fully Subscribed. Another 90,000 No. of equity shares of Rs.10 each at a premium of Rs.60 per share were offered to the employees but only 42,000 shares were subscribed. 

Merind Limited Delisted Share Details As of March 31,2025

Merind Limited Incorporation Details    

           Board of Directors of Merind Limited

           Shareholding Pattern of Merind Limited (as on 31^st March 2025)

Q: What is the face value of Merind Ltd shares?
Answer: The face value of Merind Ltd is ₹10 per equity share.

Q: What is the minimum lot size for buying Merind Ltd shares through WWIPL?
Answer: The minimum lot size for Merind Ltd shares is 100 equity shares.

Q: How can I buy Merind Ltd unlisted shares through WWIPL?
Answer: Investors can complete KYC, confirm the transaction details with WWIPL, transfer funds, and receive the shares directly in their Demat account.

Q: Why should I buy Merind Ltd shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and end-to-end support for investing in unlisted shares.

Q: Is investing in Merind Ltd a good idea?
Answer: Investors generally evaluate Merind Ltd based on its pharmaceutical manufacturing business, legacy operations, and long-term value potential within the healthcare sector.

Q: Why do investors buy Merind Ltd shares before a potential IPO or corporate action?
Answer: Investors may seek exposure to legacy pharmaceutical assets and potential value unlocking through strategic actions, restructuring, or improved business performance.

Q: What business does Merind Ltd operate in?
Answer: Merind Ltd is engaged in the manufacturing and sale of bulk drugs and pharmaceutical formulations.

Q: What is the background of Merind Ltd?
Answer: Merind Ltd was incorporated in 1958 and has a long legacy in India’s pharmaceutical industry. It was earlier known as Merck Sharp & Dohme (India). The company’s name was changed to Merind Ltd in 1984 after Tata Group acquired a 50% stake from Merck & Company (USA). Later, Wockhardt made an open offer in 1998 for acquisition of the company’s equity stake.

Q: What makes Merind Ltd different from other unlisted pharma companies?
Answer: Merind Ltd is a legacy pharmaceutical company with historical multinational and Tata association, and is often viewed from a long-term restructuring and asset-value perspective.

Q: What are the key growth drivers for Merind Ltd?
Answer: Pharmaceutical demand, potential restructuring, asset utilization, product portfolio development, and strategic corporate actions are key growth drivers.

Q: What factors affect the valuation of Merind Ltd shares?
Answer: Business performance, asset base, regulatory developments, restructuring outcomes, industry conditions, and investor sentiment influence valuation.

Q: Are Merind Ltd shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor’s Demat account.

Q: Can I sell my Merind Ltd shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and availability.

Q: What documents are required to buy Merind Ltd shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

Q: What are the risks of investing in Merind Ltd shares?
Answer: Investors should consider limited liquidity, legacy business structure, regulatory risks, and uncertainty around future corporate actions.

Q: How does WWIPL help investors track Merind Ltd investments?
Answer: WWIPL provides company updates, transaction assistance, and ongoing investment support to help investors stay informed.

Q: How long does it take for Merind Ltd shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor’s Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in Merind Ltd?
Answer: Investors should assess the company’s financial position, pharmaceutical operations, legacy structure, and potential for future value unlocking.

Q: Can Merind Ltd benefit from any future restructuring or strategic action?
Answer: Yes. Any restructuring, asset optimization, or strategic corporate action could potentially support long-term value creation for shareholders.